Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances •
Takeda Cambridge, Dimerix In Second GPCR Pact

April 13, 2011
Dimerix Bioscience Pty Ltd. has entered into a second research program with Takeda Cambridge Ltd., a UK based subsidiary of Takeda Pharmaceutical Co.  Read More »
Access Enters RNAi Delivery Pact

April 13, 2011
Access Pharmaceuticals, Inc. has entered into an agreement with a major pharmaceutical company to use its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.   Read More »
Pieris, Daiichi Sankyo In Anticalin Development Deal

April 12, 2011
Pieris AG has entered into a collaboration and license agreement with Daiichi Sankyo Co. Ltd., under which Pieris will apply its Anticalin scaffold technology to discover novel Anticalins against two Daiichi Sankyo targets.   Read More »
Novartis Discontinues Tasigna in GI Cancer

April 12, 2011
Novartis AG is discontinuing development of Tasigna as a treatment for cancerous tumors of the gastrointestinal tract.  Read More »
NSF-DBA

April 12, 2011
NSF-DBA has added five pharmaceutical experts to provide consulting and in-house training services to help companies comply with international regulations and improve quality management systems.  Read More »
Orasi, Biogen Enter Biomarker Technology Pact

April 12, 2011
Orasi Medical has entered into an agreement with Biogen Idec to test novel biomarkers for the development of treatments for central nervous system (CNS) disorders.  Read More »
Roche, Lonza Enter Assay Distribution Pact

April 11, 2011
Roche and Lonza have entered into a distribution agreement for the commercialization of Roche’s MycoTOOL mycoplasma PCR assays.   Read More »
Astellas Pharma Europe

April 11, 2011
Ken Jones has been appointed president and chief executive officer of Astellas Pharma Europe Ltd. (APEL), the European subsidiary Astellas Pharma, Inc.  Read More »
Merck, Sun Pharma Establish Generics JV

April 11, 2011
Merck & Co. and Sun Pharmaceutical Industries have created a joint venture to develop, manufacture and commercialize new combinations and formulations of branded generics in emerging markets.  Read More »
Biogen MS Drug Shows Promise

April 11, 2011
Biogen Idec achieved positive results from DEFINE, a Phase III trial to evaluate the investigational oral compound BG-12 (dimethyl fumarate) as a monotherapy in people with relapsing-remitting multiple sclerosis (RRMS).  Read More »
Invega Approved for Schizophrenia in Adolescents

April 11, 2011
Johnson & Johnson received approval from the FDA for Invega (paliperidone) extended-release tablets for the treatment of schizophrenia in adolescents 12 to 17 years of age.  Read More »
Eisai Expands into Brazil

April 8, 2011
Eisai Inc. has established a subsidiary in Brazil called Eisai Participações Ltda. (Eisai Brazil), which will be based in Sao Paulo.  Read More »
Amgen Buys Brazilian Pharma

April 8, 2011
Amgen has expanded its operations into Brazil with the acquisition of Bergamo, a privately held Brazilian pharmaceutical company, for approximately $215 million.   Read More »
Impax, Banner Pharmacaps Enter Softgel Supply Pact

April 8, 2011
Impax Laboratories has entered into a collaboration with Banner Pharmacaps to supply and commercialize two undisclosed softgel capsule products.  Read More »
Aptar Pharma’s French Labs Registered with FDA

April 8, 2011
Pharma’s French manufacturing sites in Le Vaudreuil and Val-de-Reuil have been registered as contract test labs for extractables testing with the FDA.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: